Unit
- Blood bank operations encompass the collection, testing, processing, storage, and distribution of blood and blood components. These activities are heavily regulated to ensure patient safety and product quality.
- Regulatory oversight comes primarily from the Food and Drug Administration (FDA) in the United States. The FDA sets standards for donor eligibility, testing requirements, and manufacturing practices.
- Accreditation organizations such as AABB (formerly American Association of Blood Banks) provide additional standards and voluntary accreditation. Compliance with AABB standards is often required for hospital blood banks.
- Good Manufacturing Practices (GMP) apply to blood establishments as they produce biological products. GMP regulations cover facilities, equipment, personnel, and documentation.
- Quality system essentials include organization, personnel, equipment, supplier issues, process control, documents and records, incidents, assessments, and process improvement.
- Blood bank personnel must be trained and competent in their specific roles. Continuing education and proficiency testing are required to maintain skills.
- Legal and ethical considerations include informed consent for donors, confidentiality of donor and patient information, and equitable distribution of blood products.
- International perspective shows that while many countries have similar frameworks, specific requirements vary. The World Health Organization provides guidelines for blood safety worldwide.
- Donor screening and eligibility requires a detailed health history questionnaire, vital signs check, hemoglobin screening, and review of deferral criteria. Deferrals are based on travel, medications, medical conditions, and high risk behaviors to minimize the risk of transfusion transmitted infections. Strict adherence to FDA criteria protects both donor and recipient.
- Blood component preparation uses centrifugation and separation to produce red cells, platelets, plasma, and cryoprecipitate from whole blood. Each component has unique storage requirements and shelf lives. Leukoreduction, irradiation, and pathogen reduction technologies may be applied to enhance safety for specific patient populations.
- Storage and transportation of blood products must maintain strict temperature control per FDA requirements and AABB standards. Red cells are stored at 1 to 6 degrees Celsius, platelets at 20 to 24 degrees Celsius with continuous agitation, and plasma at minus 18 degrees Celsius or colder. Continuous monitoring devices and alarm systems document compliance.
- Traceability and labeling are critical to prevent errors throughout the blood bank. Every unit is assigned a unique donation number linking donor, processing, testing, and recipient. Labels must clearly indicate component type, expiration date, ABO and Rh group, and any special processing such as irradiation or leukoreduction.
- Adverse event reporting and hemovigilance systems track transfusion reactions, errors, and near misses. Blood banks must investigate and report serious adverse events to the FDA and to AABB. Continuous analysis of these events leads to improved safety protocols, better training, and enhanced patient outcomes.
Regulatory Note
Regulation: FDA 21 CFR Parts 606, 610, and 640 govern blood banking. These regulations cover current good manufacturing practices (cGMP) for blood and blood components, donor eligibility, and labeling requirements.
Reference: FDA Code of Federal Regulations, Title 21, 2024 edition.
Quick Revision
- Blood bank operations include collection, testing, processing, storage, and distribution of blood products under strict regulation.
- FDA and AABB provide primary regulatory and accreditation standards for blood banks.
- GMP and quality system essentials ensure product safety and process control.
- Personnel training, legal ethics, and international guidelines complete the regulatory landscape.